The afternoon of day 2 at Asembia’s AXS25 Summit offered various intriguing sessions to pick from, including one on ...

A multi-national study reveals over half of older adults in several European countries are prescribed five or more ...

Subject matter experts share the challenges that patients face in terms of medication affordability, along with the role that ...

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar ...

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in rare disease care through patient-centric services, hub innovation, and ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Paul Levesque, CEO of ...

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug ...

The Zensights Federated Healthcare Advisory Panel explores how shifting global dynamics are reshaping access and strategic planning across the healthcare system. The second day of Asembia’s AXS25 ...

The company’s branded form of nadofaragene firadenovec-vncg will also be produced at a hub in Parsippany, NJ.

Amy Niles, chief mission officer, PAN Foundation, discusses the latest changes to the Medicare program that have the potential to improve patient access to care, along with the work needed to generate ...

Blake Powers, CEO, Medigi, discusses how face-to-face collaboration and streamlined commercialization strategies are helping life sciences companies deliver therapies more efficiently to patients.